BIT
AST.WS

BlackRock Institutional Trust’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

BlackRock Institutional Trust’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2K Hold
2,856
– – ﹤0.01% 3820
2016
Q3 		$1K Hold
2,856
– – ﹤0.01% 3866
2016
Q2 		$1K Buy
+2,856
New +$1.49K ﹤0.01% 3878

Other funds holding AST.WS

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock Institutional Trust's AST.WS Position: Q4 2016 in Review

BlackRock Institutional Trust held its Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) position steady in Q4 2016 at 2,856 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3820.

BlackRock Institutional Trust first reported a position in AST.WS in Q2 2016 and has held it in 3 quarters since. 36 funds tracked by Wall St. Rank hold AST.WS as of Q4 2016.

  • BlackRock Institutional Trust held 2,856 shares of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) worth $2K as of Q4 2016.
  • BlackRock Institutional Trust left its Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) share count unchanged in Q4 2016.
  • Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3820 holding.
  • BlackRock Institutional Trust first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and has held it in 3 quarters since.
  • 36 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.